HealthCystic fibrosis drug halts lung damage in young children Orkambi targets the most common mutation for cystic fibrosis, but is not available in the UK on the NHS. Now a trial has shown promising effects in children News
HealthA small class-action lawsuit could stop the US opioid epidemic A lawsuit settlement in Canada against Purdue, the pharmaceutical giant behind Oxycontin, offers a legal strategy for felling a giant with a thousand cuts Analysis